[{"Assets_0_Q1_USD":454341000.0,"CommonStockSharesConverted_0_Q1_shares":59003644.0,"CommonStockSharesOutstanding_0_Q1_shares":59003644.0,"EarningsPerShareBasic_1_Q1_USD":-0.74,"NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":-28018000.0,"StockholdersEquity_0_Q1_USD":385316000.0,"NetIncomeLossConverted_1_Q1_USD":-21738000.0,"RevenuesConverted_1_Q1_USD":11546000.0,"Ticker":"RVMD","CIK":"1628171","name":"REVOLUTION MEDICINES, INC.","OfficialName":"Revolution Medicines Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1775342076.0","Country":"United States","Sector":"Consumer Durables","Industry":"Specialty Chemicals","Market":"NASDAQ","SP500":"nan","filed":"20200514"}]